Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm. - Wikidata - awgldk - TriplyDB

Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.

Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.

http://www.wikidata.org/entity/Q46086834

about

Helicobacter pylori Antibody Titer and Gastric Cancer Screening Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis.The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis Analysis of negative result in serum anti-H. pylori IgG antibody test in cases with gastric mucosal atrophy.Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancer.Endoscopic findings of the gastric mucosa during long-term use of proton pump inhibitor - a multicenter study.Association between Gastric Cancer Risk and Serum Helicobacter pylori Antibody Titers.Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.Helicobacter pylori-negative gastric cancer: advanced-stage undifferentiated adenocarcinoma located in the pyloric gland area.Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening.

P2860

Q26780322-8DA3C64B-F21F-42F5-A827-FE3DB5A6CF68 Q35615105-E969B67F-F870-4060-88F1-CCE1B4338EA9 Q36891967-51637C5D-F204-40C0-9B54-CEB42C1D0069 Q37247031-8BB04C72-1D51-427C-9283-2CC912E7659B Q37397372-09500D4D-E0AC-4CD4-AB9D-EB6C8FEEE425 Q38796237-FFB63683-C811-4F7B-A191-247A0335FD78 Q40142376-CE87972B-CFA5-4250-BA5B-1E2AD5F3E1FF Q40189054-658A00FD-FBA9-46CB-9C2A-54F591B5AC86 Q40273393-C52066D5-760A-40EA-8E4B-1BEE49E783FB Q40394526-3ADAC95E-5BA6-4754-806D-E2C3ECC4FB13 Q40484558-D4316F26-1280-4B93-9C46-46351699B5C4 Q41231085-FF6A955C-96A6-4364-B749-1148FC0549DD Q55074295-B327F1B5-8C75-49F2-9DB0-E4C571F81A82

P2860

Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.

http://www.wikidata.org/entity/Q46086834

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Advanced method for evaluation ...... subjects for gastric neoplasm.

@en

Advanced method for evaluation ...... subjects for gastric neoplasm.

@nl

type

label

Advanced method for evaluation ...... subjects for gastric neoplasm.

@en

Advanced method for evaluation ...... subjects for gastric neoplasm.

@nl

prefLabel

Advanced method for evaluation ...... subjects for gastric neoplasm.

@en

Advanced method for evaluation ...... subjects for gastric neoplasm.

@nl

P1433

Q46086834-22C8262A-1556-4D3C-89E5-4383EC606AC9

P1476

Q46086834-044B439D-2E9A-410F-9000-93A3F3A91D48

P2093

Q46086834-31D8A7A9-C5F3-4181-84FC-4AA07D81FA7F

Q46086834-35598B57-B6DC-4B58-BBB5-47FEFBC50721

Q46086834-3DEB37F4-0FDA-46C4-BFB3-6E065F523FC4

Q46086834-95197917-2214-4481-B52B-2F66B0BAD90B

Q46086834-A5AA55AE-890F-42A8-BC90-BDFB05D026EB

Q46086834-B683FA87-0EA6-49B2-A93E-F809BC1748A8

Q46086834-C45DE610-67FE-4F62-8846-BC460FECC356

Q46086834-D7C9E7DD-8176-4F69-8CDD-90CEE3AC70E8

P2860

Q46086834-06AAE522-3594-4739-A2DF-483045DF6EA8

Q46086834-2EF53881-BDD3-450A-A283-4BC5764BC9BC

Q46086834-2F12E297-5010-4B79-8A53-1AFEA113581F

Q46086834-7548A335-45C6-4501-8668-EE7D8B876F42

Q46086834-75732EBA-FD9A-40E1-97A8-805E93B8143E

Q46086834-83091805-76A0-4A33-8E19-C3E9D94CB923

Q46086834-8DEC76D2-8219-4F78-8EED-C764B357CAE2

Q46086834-8FA1E5B9-D0D6-4855-9253-B60EE262AEB5

Q46086834-B8D8E688-2C5D-4125-BAC0-E17318E40837

Q46086834-B91D79A6-7276-416B-A84F-C50482F0E645

P304

Q46086834-CF7D691D-D9E6-4B9F-8C46-842A15DE1C5D

P31

Q46086834-225953DB-24E9-4F97-82AE-74FCA922C322

P356

Q46086834-3EDB0E6B-3C4E-40BC-B5BB-789C16ECC2CF

P433

Q46086834-A263E666-415A-43B2-B785-2AD988DE1FA3

P478

Q46086834-D4CD5097-26B4-4236-9517-5E24D0C45083

P577

Q46086834-76C2B4A5-76F3-49B0-A974-049793E307ED

P5875

Q46086834-23106701-6428-4077-9FF5-DC1317EAE1D9

P698

Q46086834-64A70D70-305F-4E8E-A512-471A56F525CA

P356

P1433

P1476

Advanced method for evaluation ...... subjects for gastric neoplasm.

@en

P2093

Kazuaki Chayama

http://www.w3.org/2001/XMLSchema#string

Masaharu Yoshihara

http://www.w3.org/2001/XMLSchema#string

Masanori Ito

http://www.w3.org/2001/XMLSchema#string

Shinji Tanaka

http://www.w3.org/2001/XMLSchema#string

Shiro Oka

http://www.w3.org/2001/XMLSchema#string

Taiji Matsuo

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Boda

http://www.w3.org/2001/XMLSchema#string

Yoko Kitamura

http://www.w3.org/2001/XMLSchema#string

P2860

Helicobacter pylori infection and the development of gastric cancer

Helicobacter pylori infection and the risk of gastric carcinoma

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers.

Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach.

Epstein-Barr virus-associated gastric carcinoma.

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HEL.12101

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258442990

http://www.w3.org/2001/XMLSchema#string

P698

24215601

http://www.w3.org/2001/XMLSchema#string